Breaking News

How lessons from AIDS crisis are shaping monkeypox response; Moderna says Omicron-containing booster outperforms current vaccine

  

 

Daily Recap

How the hard lessons of the AIDS crisis are shaping the response to the monkeypox outbreak

By Jason Mast

Mario Suriani/AP

How do you get information about a disease to those who need it without wrongly implying that only that group is at risk? There are ways.

Read More

Moderna says Omicron-containing booster outperforms current vaccine

By Matthew Herper

Karen Ducey/Getty Images

The company said it plans to submit its data to the FDA and that it hopes that the new booster will be available in the late summer.

Read More

Opinion: STAT+: How the U.S. can mitigate and prevent medical device shortages

By Michael J. Alkire and Soumi Saha

Mario Tama/Getty Images

The public and private sectors must collaborate to develop better ways to predict and prevent the disruption of medical device supplies.

Read More

STAT+: FTC will investigate pharmacy benefit managers and their role in prescription drug costs

By Ed Silverman

APStock

“This study will shine a light on these companies’ practices and their impact on pharmacies, payers, doctors, and patients," said the FTC.

Read More

Homeless and incarcerated people in Minnesota struggled to access Covid vaccines

By Kate Sheridan

KEREM YUCEL/AFP via Getty Images

Homeless and incarcerated people in Minnesota had significantly lower Covid vaccination rates than others, according to a new study.

Read More

Opinion: FDA user fee legislation needs to mitigate the pharmaceutical industry's carbon pollution

By David Introcaso

KENZO TRIBOUILLARD/AFP via Getty Images

The reauthorization of the Prescription Drug User Fee Act must not ignore the pharmaceutical industry's contributions to the climate crisis.

Read More

Wednesday, June 8, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments